Earnings History Data for Merck & Company, Inc. (MRK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Merck & Company, Inc.

Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
31-10-2024	PM		MRK	Merck & Company, Inc.	262,940	1.57	1.50	2.13	Merck Non-GAAP EPS of $1.57 in-line, revenue of $16.7B beats by $190M [10/31/2024 6:31 AM]	102.31	-2.52 (-2.40%)	101.33	-3.50 (-3.34%)	98.60 - 134.63	13,693,647	9,740,000	109,200
Merck Q3 Earnings Preview: Focus on Winrevair and Keytruda [10/30/2024 2:00 PM] Merck Non-GAAP EPS of $1.57 in-line, revenue of $16.7B beats by $190M [10/31/2024 6:31 AM] Merck in charts: KEYTRUDA continues to show an upward trend past 3 years, rises ~17% in Q3 [10/31/2024 6:42 AM] Merck narrows outlook; Keytruda drives Q3 beat despite Gardasil impact [10/31/2024 10:04 AM] Merck earnings top estimates amid solid demand for Keytruda cancer drug [2024-10-31 07:09AM] Merck: Q3 Earnings Snapshot [2024-10-31 06:37AM] Merck third quarter better than expected, but Gardasil sales sag in China again [2024-10-31 06:35AM] Will Merck's Guidance Cut Prove Gruesome In The Wake Of Januvia, Gardasil Misses? [2024-10-31 06:30AM] Merck Announces Third-Quarter 2024 Financial Results [2024-10-31 06:30AM] Merck & Co., Inc. (MRK): A Bull Case Theory [Oct-30-24 12:44PM] Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is Too Low [Oct-30-24 01:29AM]
30-07-2024	PM		MRK	Merck & Company, Inc.	318,750	2.28	2.16	-2.06	Merck Non-GAAP EPS of $2.28 beats by $0.14, revenue of $16.1B beats by $260M [7/30/2024 6:31 AM]	115.38	-12.40 (-9.70%)	123.00	-4.78 (-3.74%)	99.14 - 134.63	30,132,805	7,010,000	815,100
Merck Q2 Earnings Preview: Beat/raise likely with focus on Winrevair launch [7/29/2024 2:07 PM] Merck Non-GAAP EPS of $2.28 beats by $0.14, revenue of $16.1B beats by $260M [7/30/2024 6:31 AM] Merck in charts: KEYTRUDA shows consistent growth past 3 years, rises ~16% in Q2 [7/30/2024 6:49 AM] Biggest stock movers today: PYPL, SOFI, TLRY, CRWD, and more [7/30/2024 10:00 AM] Merck nears seven-month low on guidance cut (update) [7/30/2024 1:41 PM]
25-04-2024	PM		MRK	Merck & Company, Inc.	321,340	2.07	1.94	1.40	Merck Non-GAAP EPS of $2.07 beats by $0.15, revenue of $15.8B beats by $600M [4/25/2024 6:32 AM]	130.67	3.67 (2.89%)	129.09	2.09 (1.65%)	99.14 - 133.10	10,019,860	6,860,000	88,339
Merck raises guidance as Keytruda sales jump 20% in Q1 [4/25/2024 7:10 AM] Merck in charts: Pharmaceutical segment soars on KEYTRUDA, GARDASIL strength in Q1 [4/25/2024 6:59 AM] Merck Non-GAAP EPS of $2.07 beats by $0.15, revenue of $15.8B beats by $600M [4/25/2024 6:32 AM] Merck Q1 Earnings Preview: Strong quarter expectations on the back of core products' growth [4/24/2024 10:03 AM]
01-02-2024	PM		MRK	Merck & Company, Inc.	307,330	0.03	-0.10	1.62	Merck Non-GAAP EPS of $0.03 beats by $0.14, revenue of $14.6B beats by $120M [2/1/2024 6:31 AM]	126.24	5.46 (4.52%)	122.66	1.88 (1.56%)	99.14 - 126.33	9,262,007	8,170,000	46,892
Earnings preview: Merck slated to report before market open Thursday [1/31/2024 6:13 PM] Merck Non-GAAP EPS of $0.03 beats by $0.14, revenue of $14.6B beats by $120M [2/1/2024 6:31 AM] Merck in charts: KEYTRUDA and GARDASIL sales surged more than 20% in Q4 [2/1/2024 6:57 AM] Merck posts Q4 beat as Keytruda outperforms [2/1/2024 7:28 AM]
26-10-2023	PM		MRK	Merck & Company, Inc.	261,440	2.13	1.94	1.85	Merck Non-GAAP EPS of $2.13 beats by $0.18, revenue of $16B beats by $730M [10/26/2023 6:31 AM]	105.58	1.95 (1.88%)	103.50	-0.13 (-0.13%)	97.33 - 119.65	8,547,685	7,320,000	29,763
Merck ends trial for oral Alzheimer’s candidate amid liver toxicity cases [10/25/2023 12:38 PM] Merck Non-GAAP EPS of $2.13 beats by $0.18, revenue of $16B beats by $730M [10/26/2023 6:31 AM] Merck lifts 2023 outlook amid strong sales for COVID-19 pill [10/26/2023 7:05 AM] Merck in charts: Pharmaceutical sales up 10% Y/Y, led by KEYTRUDA and GARDASIL [10/26/2023 7:20 AM]
01-08-2023	PM		MRK	Merck & Company, Inc.	269,830	-2.06	-2.17	1.87	Merck Non-GAAP EPS of -$2.06, revenue of $15B beats by $560M [8/1/2023 6:32 AM]	105.27	-1.38 (-1.29%)	108.00	1.35 (1.27%)	84.52 - 119.65	7,998,118	7,410,000	126,717
Merck looks to continue streak of EPS beats with Q2 results [7/31/2023 4:30 PM] Merck Non-GAAP EPS of -$2.06, revenue of $15B beats by $560M [8/1/2023 6:32 AM] Merck raises sales guidance despite buyout impact on bottom line [8/1/2023 7:26 AM]
27-04-2023	PM	6:30 AM ET (Apr 27)	MRK	Merck & Company, Inc.	295,720	1.40	1.34	2.14	Merck Non-GAAP EPS of $1.40 beats by $0.03, revenue of $14.48B beats by $660M [4/27/2023 6:31 AM]	115.05	1.62 (1.43%)	115.00	1.57 (1.38%)	83.05 - 116.86	8,022,210	5,680,000	109,360
Merck, AstraZeneca dip as FDA reviews cancer drug ahead of AdCom meeting [4/26/2023 12:34 PM] Will the Keytruda wave buoy Merck's Q1 results once again? [4/26/2023 11:48 AM] Merck Non-GAAP EPS of $1.40 beats by $0.03, revenue of $14.48B beats by $660M [4/27/2023 6:31 AM] Merck trades higher as Keytruda, Gardasil drive Q1 growth amid COVID pill decline [4/27/2023 7:35 AM]
02-02-2023	PM	6:30 AM ET (Feb 2)	MRK	Merck & Company, Inc.	268,980	1.62	1.56	1.80	Merck Non-GAAP EPS of $1.62 beats by $0.08, revenue of $13.8B beats by $140M [2/2/2023 6:31 AM]	103.38	-3.60 (-3.37%)	104.54	-2.44 (-2.28%)	72.88 - 115.49	13,325,101	8,060,000	186,607
Merck COVID-19 pill linked to virus mutations – study [2/1/2023 3:55 PM] Merck Q4 results in focus with eye on future beyond Keytruda [2/1/2023 11:18 AM] Merck Non-GAAP EPS of $1.62 beats by $0.08, revenue of $13.8B beats by $140M [2/2/2023 6:31 AM] FDA removes positive COVID test requirement for Pfizer, Merck COVID-19 pills [2/2/2023 6:56 AM] Merck stock dips as Q4 earnings decline, FY23 outlook seen below estimates [2/2/2023 7:18 AM]
27-10-2022	PM	6:30 AM ET (Oct 27)	MRK	Merck & Company, Inc.	247,530	1.85	1.67	1.75	Merck Non-GAAP EPS of $1.85 beats by $0.14, revenue of $15B beats by $950M, raises FY22 outlook [10/27/2022 6:31 AM]	99.72	1.31 (1.33%)	99.75	1.34 (1.36%)	71.50 - 101.50	9,561,705	9,790,000	133,111
Merck names CEO Robert Davis as chairman [10/26/2022 5:04 PM] Merck Non-GAAP EPS of $1.85 beats by $0.14, revenue of $15B beats by $950M, raises FY22 outlook [10/27/2022 6:31 AM] Merck posts Q3 beat as Keytruda offsets sales impact on COVID-19 pill [10/27/2022 7:09 AM] Merck Shuffles Board Chairmen [Oct-26-22 08:29PM] Merck's CEO to succeed Ken Frazier as chairman [Oct-26-22 05:28PM] Merck's CEO to succeed Ken Frazier as chairman [Oct-26-22 05:22PM] Robert M. Davis to Succeed Kenneth C. Frazier as Chairman of Merck [Oct-26-22 05:00PM] Drug/Biotech Stocks' Q3 Earnings on Oct 27: MRK, GILD & More [Oct-26-22 02:48PM] 10 Best Dow Jones Dividend Stocks that Hedge Funds Love [Oct-26-22 02:47PM] Is Merck Moving Toward Another Blockbuster Drug Launch? [Oct-26-22 09:53AM]
28-07-2022	PM	6:30 AM ET (Jul 28)	MRK	Merck & Company, Inc.	227,870	1.87	1.68	1.31	Merck Non-GAAP EPS of $1.87 beats by $0.16, revenue of $14.6B beats by $750M [7/28/2022 6:33 AM]	89.96	-1.27 (-1.39%)	91.33	0.10 (0.11%)	70.89 - 95.72	12,089,003	7,900,000	39,634
Abbott, Merck under Wyden scrutiny for not providing offshore taxable income info [7/27/2022 1:48 PM] COVID-19 pill demand in focus for Merck's Q2 earnings [7/27/2022 10:34 AM] Merck Non-GAAP EPS of $1.87 beats by $0.16, revenue of $14.6B beats by $750M, raises FY22 revenue guidance [7/28/2022 6:33 AM] Merck Q2 sales soar on back of COVID drug Lagevrio, Keytruda; raises/narrows FY22 outlook [7/28/2022 7:38 AM] Drug, Biotech Stocks' Q2 Earnings on Jul 28: MRK, PFE & More [Jul-27-22 02:23PM] Stocks: Tech leads gains, home builders fall, Sherwin-Williams sinks [Jul-27-22 10:18AM] Merck avoided billions in U.S. tax by offshoring Keytruda profits - senator [Jul-27-22 10:07AM] Merck avoided billions in U.S. tax by offshoring Keytruda profits - senator [Jul-27-22 10:00AM] Merck Tops Profit Estimates on Strong Keytruda and Gardasil Sales [Jul-28-22 06:44AM] Merck quarterly profit tops Wall Street view on strong Keytruda sales [Jul-28-22 06:32AM] Merck Announces Second-Quarter 2022 Financial Results [Jul-28-22 06:30AM] Merck Eyes 50-Day Line As Profit Triples And Keytruda Passes $5 Billion Mark [Jul-28-22 09:06AM]
28-04-2022	PM	6:30 AM ET (Apr 28)	MRK	Merck & Company, Inc.	213,600	2.14	1.81	1.40	Merck Non-GAAP EPS of $2.14 beats by $0.31, revenue of $15.9B beats by $1.26B [4/28/2022 6:31 AM]	88.53	4.12 (4.88%)	85.20	0.79 (0.94%)	69.46 - 91.40	18,602,284	10,690,000	36,217
Merck Q1 result a litmus test for COVID-19 pill demand [4/27/2022 11:26 AM] Merck Non-GAAP EPS of $2.14 beats by $0.31, revenue of $15.9B beats by $1.26B [4/28/2022 6:31 AM] Merck 1Q revenue jumps 50% as COVID pill generates over $3 billion sales [4/28/2022 7:31 AM] Former U.S. Surgeon General talks Faucis pandemic comments, COVID vaccines for kids, mask mandates [Apr-27-22 05:01PM] Drug/Biotech Stocks Q1 Earnings Due on Apr 28: MRK, LLY & More [Apr-27-22 02:03PM] Why Earnings Season Could Be Great for Merck (MRK) [Apr-27-22 08:40AM] The Zacks Analyst Blog Highlights Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan [Apr-27-22 06:39AM] Merck quarterly profit tops expectations on demand for COVID pill, cancer drugs [Apr-28-22 06:30AM] Merck Announces First-Quarter 2022 Financial Results [Apr-28-22 06:30AM] Merck shares pop premarket after earnings beat as COVID antiviral sales top $3 billion [Apr-28-22 07:02AM] Merck profit tops expectations on demand for COVID pill, cancer drugs [Apr-28-22 06:41AM] Merck Notches Quarterly Beat As Covid Pill Brings In $3.2 Billion In Sales [Apr-28-22 08:39AM] Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates [Apr-28-22 07:45AM] Merck raises 2022 forecast as COVID pill, cancer drug fuels profit beat [Apr-28-22 06:41AM] Merck stock pops on earnings beat, COVID treatment sales [Apr-28-22 09:41AM] Could This FDA Approval Be a Boost for Merck? [Apr-28-22 10:23AM] IBD Stock Of The Day Merck Notches Quarterly Beat As Covid Pill Brings In $3.2 Billion [Apr-28-22 11:35AM] Robinhood, Apple, Amazon set to report earnings after the bell [Apr-28-22 12:08PM] Merck & Co. (MRK) Q1 2022 Earnings Call Transcript [Apr-28-22 12:30PM] Merck (MRK) Q1 Earnings & Sales Beat, COVID Drug Adds $3.3B [Apr-28-22 11:34AM] COVID-19: Moderna asks FDA to authorize vaccine for young kids, Merck antiviral pill sales top $3B [Apr-28-22 03:33PM] The Pandemics Impact on Merck Is Lessening, CFO Says [Apr-28-22 04:26PM]
03-02-2022	PM	6:30 AM ET (Feb 3)	MRK	Merck & Company, Inc.	205,810	1.80	1.41	1.32	Merck Non-GAAP EPS of $1.80 beats by $0.28, revenue of $13.52B beats by $380M [2/3/2022 6:31 AM]	79.00	-3.01 (-3.68%)	82.01	0.0 (0.00%)	68.38 - 91.40	16,336,623	14,650,000	80,928
Will Merck beat Q4 forecast amid COVID-19 pill buzz? [2/2/2022 9:35 AM] Merck Non-GAAP EPS of $1.80 beats by $0.28, revenue of $13.52B beats by $380M [2/3/2022 6:31 AM] Merck tops Q4 forecast; sees COVID-19 pill sales of $5B-$6B in FY22 [2/3/2022 7:44 AM] JB Capital LLC Buys iShares Core Total USD Bond Market ETF, BTC iShares U.S. ... [Feb-02-22 05:38PM] RMR Wealth Builders Buys Vanguard S&P 500 ETF, Vanguard Growth ETF, Vanguard Value ETF, ... [Feb-02-22 05:38PM] Stony Point Wealth Management Inc. Buys Vulcan Materials Co, Starwood Property Trust Inc, ... [Feb-02-22 05:38PM] Misinformation and political polarization responsible for lagging U.S. vaccinations: Dr. Emanuel [Feb-02-22 03:50PM] Sorrento Therapeutics CEO details Covishield neutralizing antibody [Feb-02-22 03:38PM] Were Hedge Funds Right About Merck & Co., Inc. (MRK)? [Feb-02-22 03:25PM] Smith Group Asset Management, LLC Buys Zebra Technologies Corp, Pfizer Inc, American Express ... [Feb-02-22 01:38PM] Truepoint, Inc. Buys Avantis Emerging Markets Equity ETF, Vanguard Intermediate-Term Corporate ... [Feb-02-22 01:38PM] Drug/Biotech Stocks Earnings on Feb 3: BIIB, LLY & MRK [Feb-02-22 12:31PM] Everett Harris & Co Buys Bank of America Corp, Becton, Dickinson and Co, Comcast Corp, ... [Feb-02-22 09:38AM] Giving Back: How Our Pro Bono Program Drives Positive Change [Feb-02-22 09:15AM] AbbVie (ABBV) Tops Q4 Earnings Estimates [Feb-02-22 09:05AM] Barnett & Company, Inc. Buys iShares Russell 1000 Growth ETF, iShares Russell 1000 Value ... [Feb-02-22 09:38PM] Merck sees 2022 sales up nearly 20%, mostly on molnupiravir [Feb-03-22 06:30AM] Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results [Feb-03-22 06:30AM] Merck tops Q4 estimates as COVID antiviral chalks up $952 million of sales [Feb-03-22 06:51AM] Price of COVID treatments from Pfizer, Merck, GSK align with patient benefits -report [Feb-03-22 08:00AM] Merck (MRK) Q4 Earnings and Revenues Beat Estimates [Feb-03-22 07:45AM] Social media stocks fall on Meta rerating, Qualcomm shares down, pharmaceutical stocks decline [Feb-03-22 10:02AM] Meta Platforms, Spotify, Biogen Fall Premarket; T-Mobile Rises [Feb-03-22 03:18AM] UPDATE 1-Merck sees 2022 sales up nearly 20%, mostly on new COVID pill [Feb-03-22 10:47AM] Merck sees 2022 sales up nearly 20%, mostly on new COVID pill [Feb-03-22 06:33AM] Facebook Shares Hammered, Driving Markets Lower [Feb-03-22 10:41AM] Merck (MRK) Q4 Earnings & Sales Beat, COVID Drug Adds $952M [Feb-03-22 11:46AM] REFILE-UPDATE 1-Merck sees 2022 sales up nearly 20%, mostly on new COVID pill [Feb-03-22 10:47AM] REFILE-Merck sees 2022 sales up nearly 20%, mostly on molnupiravir [Feb-03-22 06:30AM] Cadinha & Co Llc Buys iShares 20+ Year Treasury Bond ETF, Newmont Corp, Cisco Systems Inc, ... [Feb-03-22 05:38PM]
28-10-2021	PM	6:30 AM ET (Oct 28)	MRK	Merck & Company, Inc.	208,210	1.75	1.54	1.74	Merck EPS beats by $0.20, beats on revenue, boost outlook [10/28/2021 6:33 AM]	86.58	5.04 (6.18%)	83.50	1.96 (2.40%)	68.38 - 86.86	26,223,815	11,220,000	412,248
Merck EPS beats by $0.20, beats on revenue, boost outlook [10/28/2021 6:33 AM] Merck to double down on COVID-19 pill in 2022; raised guidance lags expectations [10/28/2021 6:57 AM] Pharma stocks rally as White House drops plan to lower drug pricing [10/28/2021 11:41 AM] Merck hits 52-week high after earnings; sees up to $7B sales for COVID-19 pill through 2022 [10/28/2021 1:35 PM] Hot Stocks: MRK high; TSLA, LCID lead EVs higher; LC pops; PRLB, BCOV fall on earnings [10/28/2021 6:17 PM] SHAREHOLDER ALERT: WeissLaw LLP Reminds COLB, XLRN, ACBI. and ECHO Shareholders About Its Ongoing Investigations [Oct-27-21 05:32PM] 'The threat of COVID is not gone," says Milwaukee medical director [Oct-27-21 04:45PM] Healthcare ETFs in Focus as Q3 Earnings Unfold [Oct-27-21 11:10AM] Biotech Stock Roundup: BMY's Q3 Earnings Beat, MRNA's Vaccine Updates & More [Oct-27-21 11:10AM] UPDATE 1-Merck signs pact to broaden generic manufacturing of COVID-19 pill [Oct-27-21 09:09AM] Should You Buy Merck & Co. (MRK) Ahead of Earnings? [Oct-27-21 08:51AM] Merck Inks Licensing Pact To Broaden Generic Manufacturing Of COVID-19 Antiviral [Oct-27-21 08:39AM] Merck Presents New Data from Ongoing Phase 2b Clinical Trial Evaluating Efficacy and Safety of Investigational Islatravir in Combination With Doravirine Through 144 Weeks for HIV-1 Treatment at EACS 2021 [Oct-27-21 06:45AM] The Medicines Patent Pool (MPP) and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countries [Oct-27-21 06:00AM] Merck signs pact to broaden generic manufacturing of COVID-19 pill [Oct-27-21 06:00AM] Merck Announces Third-Quarter 2021 Financial Results [Oct-28-21 06:30AM] Merck Stock Gains After Q3 Earnings Beat, 2021 Profit Forecast Boost [Oct-28-21 02:38AM] Merck raises full-year profit target after cancer drug sales help Q3 beat [Oct-28-21 06:41AM] Merck stock gains after profit and revenue rise above expectations, and upbeat full-year outlook [Oct-28-21 06:43AM] US STOCKS-Futures rise on positive earnings; GDP data awaited [Oct-28-21 07:24AM] 7 Stocks To Watch For October 28, 2021 [Oct-28-21 04:35AM] Merck lifts profit target as blockbuster cancer drug powers Q3 beat [Oct-28-21 06:41AM] UPDATE 3-Merck lifts profit target as blockbuster cancer drug powers Q3 beat [Oct-28-21 06:38AM] Merck Raises Annual Forecast as Profit, Sales Beat Expectations [Oct-28-21 06:48AM] Ford, Tesla, Comcast Rise Premarket; Ebay, Twilio Fall [Oct-28-21 03:53AM] India's Optimus Pharma seeks approval to produce generic Merck COVID-19 pill [Oct-28-21 08:30AM] Merck Projects Billions in Sales of Covid Antiviral Molnupiravir [Oct-28-21 09:11AM] US STOCKS-Wall Street set to rise on positive earnings, Big Tech strength [Oct-28-21 09:09AM] Merck sees up to $7 billion in sales of COVID-19 drug through end of 2022 [Oct-28-21 06:41AM] UPDATE 4-Merck sees up to $7 billion in sales of COVID-19 drug through end of 2022 [Oct-28-21 06:38AM] Merck Stock Is Gaining. Earnings Came in Strong. [Oct-28-21 08:28AM] Merck (MRK) Q3 Earnings and Revenues Beat Estimates [Oct-28-21 08:05AM] WHO, partners seek $23.4 bln for new COVID-19 war chest [Oct-28-21 10:00AM] Merck Rises as it Sees Billions in Covid Antiviral Sales [Oct-28-21 10:04AM] Yum! Brands, Comcast, Merck all beat in Q3 heres why [Oct-28-21 10:28AM] US STOCKS-Solid earnings lift mood on Wall Street ahead of Apple, Amazon results [Oct-28-21 10:26AM] UPDATE 1-WHO, partners seek $23.4 bln for new COVID-19 war chest [Oct-28-21 10:21AM] Merck's Q3 Earnings Beat Street View, Revises FY21 Outlook Below Consensus [Oct-28-21 08:06AM] Merck Rises on Outlook for Billions in Covid Antiviral Sales [Oct-28-21 11:21AM] Q3 GDP Grew Lower than Expected [Oct-28-21 09:50AM] UPDATE 2-WHO, partners seek $23.4 bln for new COVID-19 war chest [Oct-28-21 10:21AM] Merck (MRK) Beats on Q3 Earnings & Sales, Ups 2021 View [Oct-28-21 10:37AM] Jobless Claims, Q3 GDP Lower than Expected [Oct-28-21 10:35AM] Ability to vaccinate 5 year olds & up to be critical in aiding pandemic resolution: Doctor [Oct-28-21 02:21PM] US STOCKS-Nasdaq hits record high with Apple, Amazon results on deck [Oct-28-21 02:40PM] Why Merck Shares Are Making New 52-Week Highs Today [Oct-28-21 11:42AM] RPT-US STOCKS-S&P, Nasdaq hit record closing highs on earnings bullishness [Oct-28-21 06:20PM] US STOCKS-S&P, Nasdaq hit record closing highs on earnings bullishness [Oct-28-21 04:39PM] Chevron, Exxon, Personal Consumption: 3 Things to Watch [Oct-28-21 12:12PM]
29-07-2021	PM	6:30 AM ET (Jul 29)	MRK	Merck & Company, Inc.	197,120	1.31	1.30	1.37	Merck EPS misses by $0.04, beats on revenue [7/29/2021 6:31 AM]	76.96	-1.37 (-1.75%)	77.40	-0.93 (-1.19%)	68.38 - 83.72	9,453,053	8,310,000	93,899
Merck Q2 2021 Earnings Preview [7/28/2021 12:24 PM] Merck EPS misses by $0.04, beats on revenue [7/29/2021 6:31 AM] Merck narrows 2021 revenue guidance; records $600M benefit due to pandemic recovery [7/29/2021 7:26 AM] Covid-19 vaccine booster shots will become a reality: Doctor [Jul-28-21 01:51PM] Ripple effects of the CDC indoor mask guidance [Jul-28-21 01:47PM] Merck Recognized on Best Places to Work for Disability Inclusion List and Received Perfect Score on the Disability Equality Index (DEI) [Jul-28-21 08:51AM] Merck Announces Second-Quarter 2021 Financial Results [Jul-29-21 06:30AM] UPDATE 1-Merck sales rise 22% as drug demand recovers after COVID-19 hit [Jul-29-21 06:44AM] Merck stock slips after adjusted profit matches expectations, while revenue beats [Jul-29-21 06:49AM] Merck Stock Slips After Earnings, But Keytruda Sales Impress [Jul-29-21 02:49AM] Merck sales rise 22% as drug demand recovers after COVID-19 hit [Jul-29-21 06:37AM] Merck revenue beats estimates on Keytruda demand [Jul-29-21 06:37AM] Merck Stock Slips After Earnings but Keytruda Sales Impress [Jul-29-21 02:49AM] Facebook, PayPal, Uber Fall Premarket; Ford Rises [Jul-29-21 03:59AM] Merck (MRK) Q2 Earnings and Revenues Surpass Estimates [Jul-29-21 08:05AM] UPDATE 3-Merck sees recovery in non-COVID vaccine demand as quarterly sales beat estimates [Jul-29-21 06:44AM] Merck sees recovery in non-COVID vaccine demand as quarterly sales beat estimates [Jul-29-21 06:37AM] Comcast tops estimates, Merck pulls back on full-year guidance, PayPal misses on Q2 profit [Jul-29-21 10:26AM] Merck Stock Falls As Q2 Earnings Lag Wall Street Estimates, Trimmed FY21 Guidance Below Consensus [Jul-29-21 08:10AM] Merck Sales Beat Estimates, But the Stock Is Falling. Heres 1 Reason to Be Bullish. [Jul-29-21 11:36AM] UPDATE 4-Merck sees recovery in non-COVID vaccine demand as quarterly sales beat estimates [Jul-29-21 06:44AM] Merck Announces Appointment of Cristal N. Downing as Chief Communications & Public Affairs Officer [Jul-29-21 12:30PM] Merck (MRK) Q2 Earnings Miss, Sales Rebound, Stock Slips [Jul-29-21 11:24AM] We must move towards vaccine mandates to get ahead of Covid-19: Doctor [Jul-29-21 02:06PM] Healthcare Stock Sell-Off Keeps the Dow Jones From Reaching Record Levels [Jul-29-21 05:35PM]
29-04-2021	PM	6:45 AM ET (Apr 29)	MRK	Merck & Company, Inc.	196,250	1.40	1.62	1.50	Merck EPS misses by $0.22, misses on revenue [4/29/2021 6:31 AM]	73.75	-3.34 (-4.33%)	75.54	-1.55 (-2.01%)	71.72 - 87.80	26,699,932	10,390,000	200,398
Merck Q1 2021 Earnings Preview [4/28/2021 12:38 PM] Merck EPS misses by $0.22, misses on revenue [4/29/2021 6:31 AM] Merck slips 2% as Q1 trails estimates; Keytruda sales up 19% [4/29/2021 7:29 AM] Its good to lift COVID-19 restrictions right now: UAB Epidemiologist [Apr-28-21 01:32PM] Healthcare ETFs on Radar As Q1 Earnings Unfold [Apr-28-21 12:10PM] Why Merck (MRK) is a Great Dividend Stock Right Now [Apr-28-21 11:45AM] Pharma/Biotech Stocks' Q1 Earnings Queued for Apr 29: MRK, BMY & More [Apr-28-21 11:14AM] Merck & Co., Inc. to Host Earnings Call [Apr-29-21 05:45AM] Merck Announces First-Quarter 2021 Financial Results [Apr-29-21 06:30AM] UPDATE 1-Merck quarterly profit falls on COVID-19 hit [Apr-29-21 06:39AM] Merck stock drops after adjusted profit surprisingly falls, revenue comes up short [Apr-29-21 06:48AM] Merck misses profit estimates, forecasts larger hit to 2021 sales from pandemic [Apr-29-21 06:44AM] Merck Earnings Fell Short of Expectations. Heres What Caused the Miss. [Apr-29-21 07:44AM] Merck sees bigger 2021 sales hit after first quarter feels pandemic pain [Apr-29-21 06:44AM] Merck (MRK) Q1 Earnings and Revenues Lag Estimates [Apr-29-21 07:55AM] Apple, Facebook Rise Premarket; Ford, eBay Fall [Apr-29-21 03:55AM] U.S. drugmaker Merck sees bigger hit to full-year sales from pandemic [Apr-29-21 06:44AM] UPDATE 4-U.S. drugmaker Merck sees bigger hit to full-year sales from pandemic [Apr-29-21 06:39AM] What's Behind Merck's Q1 Earnings Miss [Apr-29-21 11:18AM] Merck & Co. (MRK) Q1 2021 Earnings Call Transcript [Apr-29-21 11:30AM] Merck (MRK) Q1 Earnings & Sales Miss, COVID-19 Hurts Vaccines [Apr-29-21 11:28AM] NYC reopening timeline is a disastrous issue: Doctor [Apr-29-21 01:51PM] Oncologic Drugs Adcomm Backs Merck's Keytruda, Roche's Tecentriq Accelerated Approvals In Bladder Cancer [Apr-29-21 11:47AM] AstraZeneca, Merck, AbbVie Struck Biggest Licensing Deals in 2020 [Apr-29-21 05:21PM] Why Merck Stock Dropped Today [Apr-29-21 04:26PM]
04-02-2021	PM	6:45 AM ET (Feb 4)	MRK	Merck & Company, Inc.	196,760	1.32	1.36	1.16	Merck EPS misses by $0.07, misses on revenue [2/4/2021 6:46 AM]	76.04	-0.47 (-1.65%)	76.50	-0.82 (-1.06%)	65.25 - 89.20	15,573,497	9,941,649	154,535
Merck EPS misses by $0.07, misses on revenue [2/4/2021 6:46 AM] Merck baldness drug Propecia linked to reports of suicide and suicidal behavior, Reuters reports [2/3/2021 4:27 PM] Merck CEO Kenneth C. Frazier stepping down [2/4/2021 6:49 AM] Merck Q4 Keytruda sales up 28%, 2021 guidance tops consensus [2/4/2021 7:19 AM] Negative impacts of COVID-19 pandemic weigh heavily on Merck Q4 results [2/4/2021 10:36 AM] What's Behind Merck's Disappointing Q4 Results? [Feb-04-21 02:00PM] Merck warns against using anti-parasite drug to treat COVID-19 [Feb-04-21 01:42PM] Merck expects interim data on COVID-19 drug in first quarter [Feb-04-21 12:01PM] Merck (MRK) Q4 Earnings & Sales Miss, CEO Frazier Steps Down [Feb-04-21 11:05AM] UnitedHealth Says CEO Is Leaving, Sending Shares Down [Feb-04-21 10:12AM] Dow Jones Today Leads Stocks Higher Amid EBay, PayPal Earnings, Stimulus Progress, Apple EV Buzz [Feb-04-21 09:48AM] Merck CEO Kenneth Frazier to retire at the end of June [Feb-04-21 08:59AM] Recap: Merck & Co Q4 Earnings [Feb-04-21 07:20AM] Merck CEO Kenneth Frazier to retire at the end of June [Feb-04-21 07:18AM] Kenneth C. Frazier to Retire as Merck CEO; Board Elects Robert M. Davis as Successor; Frazier to Continue as Executive Chairman [Feb-04-21 06:40AM] Merck & Co., Inc. to Host Earnings Call [Feb-04-21 06:15AM] Exclusive: Merck anti-baldness drug Propecia has long trail of suicide reports, records show [Feb-03-21 11:45PM] Exclusive: Merck anti-baldness drug Propecia has long trail of suicide reports, records show [Feb-03-21 03:10PM]
27-10-2020	PM	6:45 AM ET (Oct 27)	MRK	Merck & Company, Inc.	201,910	1.74	1.44	1.51	Merck EPS beats by $0.31, beats on revenue [10/27/2020 6:46 AM]	78.19	0.18 (-0.82%)	79.20	0.36 (0.46%)	65.25 - 92.64	9,666,414	8,330,899	49,053

31-07-2020	PM	6:45 AM ET (Jul 31)	MRK	Merck & Company, Inc.	200,290	1.37	1.14	1.30	Merck EPS beats by $0.32, beats on revenue [7/31/2020 6:47 AM]	79.38	0.39 (0.49%)	81.07	2.08 (2.63%)	65.25 - 92.64	5,692,226	8,453,125	249,356